Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...

The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory ...

Researchers sought to determine whether patients who are functional high-risk had a worse prognosis even without having traditional high-risk features.

EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical ...

GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.

Dear Dr. Roach: My wife was recently discharged after a lengthy hospital stay with multiple diagnoses. Most of her issues ...

My wife was recently discharged after a lengthy hospital stay with multiple diagnoses. Most of her issues were treated medically and resulted in six new medications from four ...

A Somerset man who was diagnosed with incurable blood cancer thanks the Taunton and Yeovil NHS teams who have been given an award for ...

Galapagos NV (NASDAQ:GLPG – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms ...

Carol Baldwin, Local Journalism Initiative Reporter, Wakaw RecorderHealth Canada announced this fall that cancer is the leading cause of job-related deaths ...